ScreenerHero

PTIXProtagenic Therapeutics, Inc.

NAS · US · Technology · Biotechnology · phytanix.com
0.8011USD+122.53%Mkt Cap: 1.45M $P/E: —

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap1.45M $
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-5.53M $
Revenue/Share—
Last Price0.8011 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees—
CountryUS
SectorTechnology
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.03
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.49
EPS (TTM)-22.51
EPS (Forward)-0.58
52W Range
0.140011% of range6.200
52W High6.200 USD
52W Low0.1400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-545.36%
ROA-282.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.22M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh-1.2370 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 27, 2016
Splits
Last Split1:14
Split DateMay 5, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.81M
Float—
Insiders4.18%
Institutions4.64%
Short Interest
Short Ratio0.6d
Short % Float3.30%
Short % Out.3.19%
Shares Short61.71K
Short (prev mo.)56.97K
Technical
SMA 500.3127 (+156.2%)
SMA 2000.7527 (+6.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)9.59K
Avg Vol (10d)10.06K
Technical Indicators
RSI (14)77.2
MACD0.0345
MACD Signal-0.0208
MACD Hist.+0.0553
BB Upper0.5609 USD
BB Middle0.2805 USD
BB Lower0.0001 USD
BB Width199.90%
ATR (14)0.0875 USD
Vol Ratio (20d)21.71x